-
Published 1/24/2026
Martinez CB, Bhatt S, Battaglini J, Beckett A, Tapan U. Lung Cancer in the Incarcerated Population: A Narrative Review. Curr Oncol Rep. 2026 Jan 24; 28(1):2. PMID: 41579227.
-
Published 1/3/2026
Battaglini J, AlDoughaim M, Li K, Patel J, Bhatt S, Everett P, Oxnard GR, Tapan U. Real-world adoption of off-label combinations for targeted therapy resistance in non-small cell lung cancer. Clin Transl Oncol. 2026 Jan 03. PMID: 41484568.
-
Published 9/1/2025
Wang J, Sajeev G, Chai X, Takundwa R, Dirnberger F, Pundole X, Pastel M, Yang H, Tapan U. Efficacy outcomes between tarlatamab and real-world physicians' choice of therapies for previously treated extensive stage small cell lung cancer. Oncologist. 2025 Sep 01; 30(9). PMID: 40839303.
-
Published 8/29/2025
Shah MV, Solem CT, Liao A, Bell KF, Wang Y, Yang H, Meng Y, Ye M, Tapan U. Patient and Physician Preferences for Maintenance Treatment in Advanced Non-Small Cell Lung Cancer: Insights into Treatment Selection. Adv Ther. 2025 Nov; 42(11):5499-5514. PMID: 40879895.
-
Published 4/15/2025
Shah MV, Solem CT, Bell KF, Aziez A, Sun X, Du M, Du EX, Yang H, Wang H, Hua Q, Tapan U. Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer. Adv Ther. 2025 Jun; 42(6):2782-2796. PMID: 40232624.